BioGX Pixl qPCR Platform
Dec 15, 2022
BioGX has launched the Pixl portable qPCR platform outside of the US. The Pixl instrument is a benchtop four-channel, 16-well, RT-PCR instrument that supports rapid turnaround times for batches of up to 16 samples, providing integrated results interpretation on a device with a compact footprint. It was previously CE-IVD marked.
The Pixl system can be used with BioGX's CE-IVD assays for COVID-19, Group A Strep, and its combo assay for COVID-19, influenza A, and influenza B. Next month, the firm expects to make available research-use assays for monkeypox, syphilis, and a combo assay for varicella-zoster virus, and herpes simplex 1 and 2 viruses.